CellType

Visibility13

Vibe79

AI Visibility & Sentiment

CellType

CellType is a biotechnology company that uses AI foundation models trained on human cell data to simulate drug response in human biology. Their technology helps pharmaceutical companies prioritize drug targets, predict toxicity, and accelerate clinical trials before testing on actual patients.

Active Monitoring

celltype.com

Biotechnology YC25-26

AI Visibility Score

13/100

Invisible

Sentiment Score

79/100

AI Perception

Summary

CellType is currently a ghost in the AI discovery engines used by high-stakes pharma executives, failing to appear in any queries for the R&D persona despite maintaining a narrow technical foothold on Claude. While industry giants like Schrödinger and Exscientia dominate the 'top player' lists that drive enterprise partnerships, CellType's 0% visibility on ChatGPT and AI Overviews represents a critical failure in the brand's digital authority.

Value Proposition

Simulate drug response in human biology before the first patient, enabling pharma companies to prioritize what to test and accelerate what works while catching toxicity signals that animal models miss.

Overview

Mission

Know how your drug works in humans before the first patient.

Products & Services

Target De-risking - virtual compound screening and target rankingTranslation & Toxicity Prediction - human adverse reaction prediction from preclinical dataClinical Acceleration - virtual patient stratification and responder identificationBiomarker Discovery - assay-ready biomarkers for go/no-go decisionsDiagnostics & Precision Health - multimodal biological data foundation models

Agent Breakdown

AI Platforms

How often do different AI platforms reference CellType?

Loading explorer...

Conversation Analysis

Topics

What conversations is CellType included in — or excluded from?

Loading explorer...

Buyer Personas

Personas

Who does each AI platform recommend CellType to, and when?

Loading explorer...

Programmatic Testing

Sample Conversations

We programmatically analyze questions that real customers are asking to AI agents and chatbots, extract brand mentions and sentiment, analyze every response, and synthesize the data into an action plan to increase AI visibility.

ChatGPT

Claude

Gemini

AI Overviews

De Risking Drug Discovery And Early Screening(3 queries)

“help me find ways to de-risk drug targets using AI before moving to animal studies”

0/4 platforms mentioned

ChatGPT

1.TwoSampleMR

2.MR-Base

3.coloc

4.SMR/HEIDI

5.gnomAD

+81 more

Claude

1.Exscientia

2.Recursion

3.BenevolentAI

4.Insitro

5.AlphaFold

+19 more

Gemini

1.BenevolentAI

2.Causaly

3.Owkin

4.AlphaFold2

5.DeepMind

+14 more

AI Overviews

1.DeepTox

2.Owkin

3.CellProfiler

4.DrugBank

5.SIDER

+1 more

“how can i use foundation models to screen virtual compounds more effectively”

0/4 platforms mentioned

ChatGPT

1.ESM

2.ProtBERT

3.AlphaFold2

4.ESMFold

5.ChemBERTa

+25 more

Claude

1.DeepChem

2.BenevolentAI

3.Exscientia

4.Recursion

Gemini

1.NVIDIA BioNeMo

2.MegaMolBART

3.IBM MoL0

4.AlphaFold

5.Recursion

+8 more

AI Overviews

1.ChemBERTa

2.VideoMol

3.LigUnity

4.OpenVS

“ways to simulate human cell response for target ranking, any specific platforms i should check out?”

0/4 platforms mentioned

ChatGPT

1.Open Targets Platform

2.DisGeNET

3.STRING

4.Broad Connectivity Map

5.L1000

+34 more

Claude

1.Emulate

2.Tissue Dynamics

3.Recursion Pharmaceuticals

4.Exscientia

5.Proven

+2 more

Gemini

1.Emulate

2.Human Emulation System

3.CN Bio

4.PhysioMimix

5.Mimetas

+10 more

AI Overviews

1.PandaOmics

2.Insilico Medicine

3.Cell Collective

4.CZI AI Cell Models Platform

5.Chan Zuckerberg Initiative

+5 more

Clinical Trial Optimization And Toxicity Prediction(1 query)

“how to predict human adverse reactions better than preclinical animal data”

0/4 platforms mentioned

ChatGPT

1.Simcyp

2.Certara

3.GastroPlus

4.Simulations Plus

5.PK-Sim

+26 more

Claude

1.Emulate

2.Celldex

3.Hurel Corporation

4.Human Emulation System

5.Simcyp

+8 more

Gemini

1.Emulate, Inc.

2.Human Emulation System

3.Mimetas

4.OrganoPlate

5.CN Bio

+14 more

AI Overviews

1.Emulate

2.Liver-Chip

Evaluating AI Biotech Partners (Trust & Reviews)(1 query)

“who are the top players in AI-driven drug discovery right now besides recursion or insitro”

0/4 platforms mentioned

ChatGPT

1.Recursion

2.Insitro

3.Exscientia

4.Bristol Myers Squibb

5.Atomwise

+19 more

Claude

1.Atomwise

2.Exscientia

3.EXS5004

4.Schrodinger

5.Benchling

+8 more

Gemini

1.Exscientia

2.Schrödinger

3.BenevolentAI

4.Eli Lilly

5.baricitinib

+16 more

AI Overviews

1.Recursion

2.Exscientia

3.insitro

4.Insilico Medicine

5.Schrödinger

+19 more

Analysis

Key Insights

What AI visibility analysis reveals about this brand

Strength

Significant resonance within Claude, achieving a 42% mention rate and reaching the #1 position for brand-specific vibe checks.

Strength

Developing a niche presence with Technical Computational Biologists (40% visibility) and Clinical Safety Leads (36%), particularly for simulation-related queries.

Strength

High sentiment scores when mentioned, indicating that while the brand is hard to find, the information available is viewed favorably.

Gap

Complete invisibility on ChatGPT and AI Overviews for all functional and category-based queries.

Gap

Zero penetration with the High-Stakes Pharma R&D Executive persona, a critical demographic for high-value biotech partnerships.

Gap

Absence from high-intent queries regarding 'top players' and 'evaluating AI biotech partners,' leaving the field open to competitors like Schrödinger and BenevolentAI.

Opportunity

Capture the 'de-risking drug targets' narrative where Claude is already showing early-stage recognition for the brand.

Opportunity

Infiltrate the 'Foundation Models' discourse by publishing technical benchmarks that AI crawlers can index for ChatGPT and Gemini.

Opportunity

Bridge the gap between technical niche recognition and executive-level authority to move from a #13 position to a top-tier recommendation.

Technical Health

Site Health for AI Visibility

How well CellType's website is optimized for AI agent discovery and comprehension.

84/100

14 passed 2 warnings 3 issues

Audited 2/27/2026

Crawlability96

Can AI bots find your pages?

Technical96

SSL, mobile, doctype basics

On-Page SEO71

Titles, descriptions, headings

Content Quality60

Word count, depth, freshness

Schema Markup85

Structured data for AI comprehension

Social & OG82

Open Graph, Twitter cards

AI Readability100

How well AI can parse your content

Critical Issues

Page has no meta description

Add a <meta name="description"> tag summarizing the page (150-160 characters).

Page has no H1 heading

Add a single H1 tag as the main page heading.

Content is too thin

Expand your content to at least 300-500 words with valuable information.

Warnings

3 render-blocking resource(s) detected

Consider deferring or async-loading non-critical scripts and stylesheets.

Few headings on page

Add more H2 and H3 headings to organize content into sections.

Few internal links on this page

Add more internal links to related pages on your site.

Missing Open Graph tags for social sharing

Add og:title, og:description, and og:image meta tags.

Want a full technical audit with AI-specific recommendations?

Run a free visibility scan

Brand Identity

Brand Voice & Style

How AI perceives CellType's communication style and personality

CellType communicates with scientific authority and precision, backed by peer-reviewed research and state-of-the-art benchmarks. The tone is confident yet accessible, translating complex computational biology into clear value propositions for drug development. There's an underlying sense of urgency and ambition—they're solving problems that matter for human health. The voice balances academic credibility (Yale, Nature, Cell publications) with startup energy (Y Combinator backing, bold claims about transforming drug discovery).

Core Tone Traits

Scientifically Authoritative

Leads with peer-reviewed publications, benchmark data, and academic credentials to establish credibility

Confidently Ambitious

Makes bold claims about transforming drug discovery, backed by evidence of real-world validation

Technically Precise

Uses specific metrics, model parameters, and quantitative results rather than vague promises

Urgently Mission-Driven

Conveys that accelerating drug discovery has real human impact and time matters

Competitive Landscape

Related Ecosystem

Related products and services that AI mentions in conversations alongside or instead of CellType

Schrödinger24 mentions

Exscientia19 mentions

BenevolentAI18 mentions

Insilico Medicine16 mentions

Emulate15 mentions

Atomwise14 mentions

Recursion14 mentions

Insitro14 mentions

AlphaFold11 mentions

MIMETAS9 mentions

CellType8 mentions

Source Intelligence

Citations

Sources that AI assistants cite. Getting featured here improves visibility.

De-risking drug discovery with predictive AI | Broad Institute

https://www.broadinstitute.org/news/de-risking-drug-discovery-predictive-ai

Referenced in 1 query

Review

The role of machine learning in predictive toxicology: A review of ...

https://www.sciencedirect.com/science/article/pii/S0024320525004564

Referenced in 1 query

Review

Can New Approach Methodologies De-Risk Drug ...

https://www.criver.com/eureka/can-new-approach-methodologies-de-risk-drug-development

Referenced in 1 query

Review

AI-based Toxicity Prediction Models using ToxCast Data

https://www.sciencedirect.com/science/article/pii/S0300483X25001891

Referenced in 1 query

Review

Roadmap to Reducing Animal Testing in Preclinical Safety ...

https://www.fda.gov/files/newsroom/published/roadmap_to_reducing_animal_testing_in_preclinical_safety_studies.pdf

Referenced in 2 queries

Review

AI in Drug Discovery and Development | Danaher Life Sciences

https://lifesciences.danaher.com/us/en/library/artificial-intelligence-in-drug-discovery.html

Referenced in 1 query

Review

Artificial Intelligence (AI) Applications in Drug Discovery and ... - PMC

https://pmc.ncbi.nlm.nih.gov/articles/PMC11510778/

Referenced in 1 query

Review

Artificial intelligence in drug discovery and development - PMC

https://pmc.ncbi.nlm.nih.gov/articles/PMC7577280/

Referenced in 1 query

Review

Therapeutic Target Identification & Validation with AI | Ardigen

https://ardigen.com/target-identification/

Referenced in 1 query

Review

How does AI assist in the early detection of drug toxicity?

https://synapse.patsnap.com/article/how-does-ai-assist-in-the-early-detection-of-drug-toxicity

Referenced in 1 query

Review

Artificial intelligence for drug discovery: Resources, methods, ... - PMC

https://pmc.ncbi.nlm.nih.gov/articles/PMC10009646/

Referenced in 1 query

Review

Artificial intelligence in preclinical research: enhancing digital ...

https://www.sciencedirect.com/science/article/pii/S135964462500073X

Referenced in 1 query

Review

Content Engineering

Recommended Actions

Execute a 'De-risking' Content Authority Campaign

CellType is currently missing from every query related to 'de-risking drug targets,' a core industry pain point where competitors are currently defining the standard.

Impact: High

Optimize for ChatGPT and AI Overview indexing via structured technical documentation

With 0% visibility on these platforms, the brand is effectively non-existent for users who rely on these tools for market mapping and vendor discovery.

Impact: High

Develop Executive-Level Whitepapers on AI Toxicity Prediction

The Clinical Safety Lead persona shows interest in CellType, but the brand lacks the authoritative content needed to climb from an average position of 7.8 into a top-3 recommendation.

Impact: Medium

Is this your business? We can help you improve your AI visibility.

Book a Free Strategy Session

Backing